Tarek A. Hammad

5.1k total citations · 1 hit paper
87 papers, 3.7k citations indexed

About

Tarek A. Hammad is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, Tarek A. Hammad has authored 87 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pediatrics, Perinatology and Child Health, 17 papers in Public Health, Environmental and Occupational Health and 17 papers in Economics and Econometrics. Recurrent topics in Tarek A. Hammad's work include Pharmacovigilance and Adverse Drug Reactions (11 papers), Pregnancy and Medication Impact (11 papers) and Pharmaceutical Economics and Policy (10 papers). Tarek A. Hammad is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (11 papers), Pregnancy and Medication Impact (11 papers) and Pharmaceutical Economics and Policy (10 papers). Tarek A. Hammad collaborates with scholars based in United States, Netherlands and Thailand. Tarek A. Hammad's co-authors include Thomas Laughren, Judith A. Racoosin, Hany Aly, G. D. Rochester, Mark Levenson, Marc B. Stone, Robert Temple, Arlene R. Hughes, Simone Pinheiro and Patricia Langenberg and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PEDIATRICS.

In The Last Decade

Tarek A. Hammad

85 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suicidality in Pediatric Patients Treated With Antidepressant Drugs

2006 734 citations Tarek A. Hammad, Thomas Laughren et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tarek A. Hammad United States	32	771	738	715	617	568	87	3.7k
Elizabeth A. Walker United States	46	403 0.5×	256 0.3×	516 0.7×	339 0.5×	516 0.9×	136	6.7k
Jesse Chittams United States	43	811 1.1×	578 0.8×	1.2k 1.7×	500 0.8×	451 0.8×	187	6.7k
Esther W. Chan Hong Kong	39	514 0.7×	684 0.9×	392 0.5×	380 0.6×	301 0.5×	296	5.7k
Franco Contaldo Italy	46	678 0.9×	371 0.5×	1.2k 1.6×	342 0.6×	400 0.7×	207	6.8k
Lara Hilton United States	22	737 1.0×	360 0.5×	509 0.7×	227 0.4×	944 1.7×	65	4.8k
James W. Anderson United States	34	867 1.1×	370 0.5×	1.4k 1.9×	435 0.7×	1.0k 1.8×	102	5.8k
Amie Steel Australia	32	405 0.5×	483 0.7×	935 1.3×	494 0.8×	466 0.8×	252	4.2k
Hind A. Beydoun United States	36	450 0.6×	564 0.8×	931 1.3×	376 0.6×	72 0.1×	161	4.8k
Kari Furu Norway	41	405 0.5×	855 1.2×	1.8k 2.5×	1.3k 2.1×	233 0.4×	157	5.0k
Peter Chedraui Ecuador	43	383 0.5×	756 1.0×	1.4k 2.0×	583 0.9×	119 0.2×	233	6.0k

Countries citing papers authored by Tarek A. Hammad

Since Specialization

Citations

This map shows the geographic impact of Tarek A. Hammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarek A. Hammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarek A. Hammad more than expected).

Fields of papers citing papers by Tarek A. Hammad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarek A. Hammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarek A. Hammad. The network helps show where Tarek A. Hammad may publish in the future.

Co-authorship network of co-authors of Tarek A. Hammad

This figure shows the co-authorship network connecting the top 25 collaborators of Tarek A. Hammad. A scholar is included among the top collaborators of Tarek A. Hammad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarek A. Hammad. Tarek A. Hammad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bate, Andrew, Jackie Brown, Gianmario Candore, et al.. (2025). Interplay of Spontaneous Reporting and Longitudinal Healthcare Databases for Signal Management: Position Statement from the Real-World Evidence and Big Data Special Interest Group of the International Society of Pharmacovigilance. Drug Safety. 48(9). 959–976. 3 indexed citations

Hammad, Tarek A., et al.. (2025). Rethinking drug safety signal detection and causality assessment in the age of AI: the risks of incomplete data and biased insights. PubMed. 5. 1678074–1678074.

Hammad, Tarek A., et al.. (2024). Strategic Partnerships in Pharmacovigilance: Business, Legal, and Regulatory Domains. Clinical Therapeutics. 46(5). 424–428.

Janssens, Rosanne, Liese Barbier, Irina Cleemput, et al.. (2023). How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action. Frontiers in Pharmacology. 14. 1192770–1192770. 5 indexed citations

Ikeoka, Kuniyasu, et al.. (2021). THE GERIATRIC NUTRITIONAL RISK INDEX PREDICTS THE PROGNOSIS IN PATIENTS WITH CHRONIC LIMB-THREATENING ISCHEMIA. Journal of the American College of Cardiology. 77(18). 1533–1533. 1 indexed citations

Pinto, Cathy Anne, Tommi Tervonen, Kevin Marsh, et al.. (2019). Personalized benefit‐risk assessments combining clinical trial and real‐world data provide further insights into which patients may benefit most from therapy: Demonstration for a new oral antiplatelet therapy. Pharmacoepidemiology and Drug Safety. 28(4). 443–451. 6 indexed citations

Soekhai, Vikas, Chiara Whichello, Bennett Levitan, et al.. (2017). Compendium Of Methods For Measuring Patient Preferences In Medical Treatment. Value in Health. 20(9). A684–A685. 6 indexed citations

Avalos, Lyndsay A., Hong Chen, Chunmei Yang, et al.. (2013). The Prevalence and Trends of Antiviral Medication Use During Pregnancy in the US: A Population-Based Study of 664,297 Deliveries in 2001–2007. Maternal and Child Health Journal. 18(1). 64–72. 5 indexed citations

Lawrence, Jean M., Susan E. Andrade, Lyndsay A. Avalos, et al.. (2013). Prevalence, Trends, and Patterns of Use of Antidiabetic Medications Among Pregnant Women, 2001-2007. Obstetrics and Gynecology. 121(1). 106–114. 27 indexed citations

10.

Margulis, Andrea V., Elizabeth M. Kang, & Tarek A. Hammad. (2013). Patterns of Prescription of Antidepressants and Antipsychotics Across and Within Pregnancies in a Population-Based UK Cohort. Maternal and Child Health Journal. 18(7). 1742–1752. 38 indexed citations

11.

Hammad, Tarek A., et al.. (2012). Review of quality assessment tools for the evaluation of pharmacoepidemiological safety studies. BMJ Open. 2(5). e001362–e001362. 15 indexed citations

12.

Du, Dongyi, et al.. (2012). Atomoxetine Use During a Period of FDA Actions. Medical Care. 50(11). 987–992. 16 indexed citations

13.

Bobo, William V., Robert L. Davis, Sengwee Toh, et al.. (2012). Trends in the Use of Antiepileptic Drugs among Pregnant Women in the US, 2001–2007: A Medication Exposure in Pregnancy Risk Evaluation Program Study. Paediatric and Perinatal Epidemiology. 26(6). 578–588. 63 indexed citations

14.

Devine, Scott, Suzanne L. West, Elizabeth Andrews, et al.. (2009). The identification of pregnancies within the general practice research database. Pharmacoepidemiology and Drug Safety. 19(1). 45–50. 54 indexed citations

15.

Hammad, Tarek A., David J. Graham, Judy A. Staffa, Cynthia Kornegay, & Gerald J. Dal Pan. (2008). Onset of acute myocardial infarction after use of non‐steroidal anti‐inflammatory drugs. Pharmacoepidemiology and Drug Safety. 17(4). 315–321. 20 indexed citations

16.

Hammad, Tarek A., Thomas Laughren, & Judith A. Racoosin. (2006). Suicide Rates in Short-term Randomized Controlled Trials of Newer Antidepressants. Journal of Clinical Psychopharmacology. 26(2). 203–207. 94 indexed citations

17.

El‐Masri, Maher M., Tarek A. Hammad, & Susan M. Fox-Wasylyshyn. (2005). Predicting Nosocomial Bloodstream Infections Using Surrogate Markers of Injury Severity. Nursing Research. 54(4). 273???279–273???279. 7 indexed citations

18.

Anderson, Mark, Margaret R. Slater, & Tarek A. Hammad. (1999). Results of a survey of small-animal practitioners on the perceived clinical efficacy and safety of an oral nutraceutical. Preventive Veterinary Medicine. 38(1). 65–73. 28 indexed citations

19.

Hanson, R. Reid, et al.. (1997). Oral treatment with a glucosamine-chondroitin sulfate compound for degenerative joint disease in horses: 25 cases. Equine practice. 19(9). 16–20. 61 indexed citations

20.

Hammad, Tarek A., et al.. (1996). Comparative evaluation of the use of artificial neural networks for modelling the epidemiology of schistosomiasis mansoni. Transactions of the Royal Society of Tropical Medicine and Hygiene. 90(4). 372–376. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact